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We aimed to examine the association between maternal adiposity and glucose metabolism in adult 
offspring without diabetes, simultaneous taking offspring own adiposity into account. 
Methods 
This longitudinal birth cohort study (Helsinki Birth Cohort Study) included 1,440 non-diabetic 
subjects examined at a mean age of 62 years. Subjects were divided into quartiles according to 
maternal body mass index (BMI). The impact of maternal BMI on offspring body composition was 
also studied. 
Results 
There were no differences in fasting glucose between the groups. In men, maternal BMI was 
inversely associated with mean 2-hour glucose concentration after a 75 g oral glucose tolerance test 
(p<0.001) and mean homeostatic model assessment of insulin resistance (HOMA-IR) (p=0.049). 
According to the subjects’ own BMI, high maternal BMI was associated with lower 2-hour glucose 
concentrations only in non-obese men and with lower HOMA-IR only in obese men. Maternal BMI 
was not associated with glucose concentrations nor with HOMA-IR in women. In addition, 
maternal BMI was positively associated with a higher offspring lean body mass in men. 
Conclusions 
High maternal BMI was associated with lower 2-hour plasma glucose concentration, especially in 
non-obese men. Offspring lean body mass may be a mediating factor for the association.  
 







The obesity epidemic is a major challenge to global health today also involving women of 
reproductive age 1,2. Maternal pre-pregnancy obesity and excess gestational weight gain during 
pregnancy are well-recognized risk factors for immediate adverse pregnancy outcomes, such as 
gestational diabetes and pre-eclampsia 3-5. Furthermore, multiple studies have recently focused on 
the impact of maternal adiposity on offspring health later in life 6.  
The mechanisms underlying the association between maternal obesity and offspring later health are 
likely to be multifactorial and to include epigenetic programming in early life 7. In animal studies, 
maternal adiposity has been found to alter the metabolic regulatory pathways of the fetus, including 
shifting the hypothalamic response to leptin, changing appetite control and altering beta cell 
function in the pancreas 8,9. Additionally, studies in human subjects show that maternal obesity is 
linked to changes in DNA methylation in sites associated with offspring adiposity, indicating 
epigenetic remodeling 10. 
In regard of cardiometabolic outcomes, maternal obesity has been linked to childhood adiposity, 
adverse body-fat distribution, adverse lipid profile, elevated blood pressure and insulin resistance in 
the offspring 11-13. Childhood body mass index (BMI) might be a mediating factor between maternal 
BMI and the other cardiometabolic outcomes 11,14. Similar results have been reported in adolescents 
and young adults 15-18.  
The associations between maternal BMI and offspring cardiometabolic outcomes in late adulthood 
have been less studied. A birth cohort study in the UK showed an association between maternal 
obesity and all-cause mortality and cardiovascular events in adult offspring 19. In previous studies 
from the Helsinki Birth Cohort Study (HBCS), we found that maternal adiposity increased the risk 
of cardiovascular disease and type 2 diabetes in the offspring. The association for type 2 diabetes 
was stronger in women.20  
In this study, we focused on the impact of maternal BMI on glucose and insulin metabolism in non-
diabetic offspring in late adulthood. Impaired fasting glucose, impaired glucose tolerance and 
insulin resistance are known risk factors for type 2 diabetes 21. Based on previous studies, we 
hypothesized that a high maternal BMI would be linked to impaired glucose regulation and insulin 
resistance in the offspring. 
 
Methods 
This study is a part of the HBCS, a cohort consisting of 13,345 subjects who were born in one of 
the two largest delivery hospitals in Helsinki in 1934-1944 and who lived in Finland in 1971, when 
all Finnish residents received a unique social security number. In 2001-2004, 2,003 cohort members 
participated in a clinical examination. This clinical cohort was obtained by sending a questionnaire 
to all subjects from HBCS born at Helsinki University Hospital and living in Finland in year 2000 
(n= 8,760). Out of the 6, 874 individuals who responded, 2,901 were randomly chosen to participate 
and, 2,003 of them did.  
In this particular study, subjects with previously and newly diagnosed diabetes were excluded 
(n=315). These subjects were identified from the nationwide prescription register of the Social 
Insurance Institution (SII) as receiving special reimbursement for diabetes medication costs 
(information available form year 1964) and/or having purchased drugs for treatment of diabetes 
(available from year 1995). In Finland, diabetes medication is partly compensated by the state, and 
in order to receive the reimbursement, one must be diagnosed by a physician and approved by a 
physician at the SII. Newly diagnosed diabetes was based upon findings in the oral glucose 
tolerance test (OGTT) performed in association with the clinical study. Additionally, 244 subjects 
were excluded because they had incomplete data on maternal weight and height and 4 subjects were 
excluded because they lacked information about diabetes. Finally, this study cohort included 1,440 
non-diabetic subjects who attended the clinical examination, had complete data on maternal weight 
and height as well as the main outcome variables in this study. 
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Information on the subjects and their mothers was collected from hospital birth records, child 
welfare records and school healthcare records. Data include information on maternal weight in late 
pregnancy, maternal height, maternal age at delivery, parity, gestational age and birth weight and 
height. Maternal BMI was calculated as late pregnancy weight/height2 and maternal body surface 
area (BSA) was calculated by using the Mosteller formula 22. We also calculated the subjects’ 
ponderal index at birth with the formula birth weight/birth height3. 
Glucose tolerance was assessed with a two-hour 75 g OGTT, and glucose concentrations were 
measured at baseline (FPG) and at two hours (2hPG) and expressed as mmol/L. Plasma insulin 
concentrations were measured at fasting and at two hours. HOMA-IR was used as a proxy for 
insulin sensitivity and HOMA-IR was calculated with the formula (fasting plasma glucose (mmol/l) 
x fasting serum insulin (mU/l))/22.5. The main outcomes were 2hPG and HOMA-IR. 
Measurements acquired at the clinical examination included subjects’ adult weight and height, waist 
circumference, lean body mass, fat percent, blood pressure, cholesterol and triglycerides 
concentrations and high sensitive C-reactive protein (hs-CRP). Subjects’ own BMI was calculated 
as adult weight/height2 and BSA by using the Mosteller formula. Blood pressure was measured 
from the right arm in a sitting position and the mean of two successive readings was used. Blood 
was drawn for the measurement of glucose, insulin, lipids and inflammatory markers. Lean body 
mass and body fat percentage were assessed by using an eight-polar tactile electrode system (Bio-
impedance, InBody 3.0). The methods used to measure glucose and insulin concentrations, blood 
pressure, cholesterol concentrations, triglyceride concentrations and hs-CRP are described in detail 
in Eriksson et al.23. Subjects’ smoking status was assessed with a questionnaire and defined as 
whether currently smoking. The amount of leisure-time physical activity (LTPA) was based on a 
12-month validated exercise questionnaire; the Kuopio Ischemic heart disease Risk Factor Study 
and physical activity was presented as metabolic equivalent of task (MET) per week 24. 
The study was approved by the Ethics Committee of Hospital District of Helsinki and Uusimaa and 




The maternal and offspring characteristics are presented as means with standard deviation (SD) for 
continuous variables and as frequencies with percentages for categorical variables. For describing 
the characteristics of the men and women they were divided into quartiles according to maternal 
BMI. The quartiles were maternal BMI <24.6 kg/m2 (quartile I), 24.6-26.2 kg/m2 (quartile II), 26.3-
28.0 kg/m2 (quartile III) and >28.0 kg/m2 (quartile IV). In further analyses the men and women were 
divided into three groups according to their own adult BMI. The BMI cutoffs for overweight and 
obesity were used, with BMI <25.0 kg/m2 in the lowest BMI group, 25.0-29.9 kg/m2 in the middle 
BMI group and ≥30 kg/m2 in the highest BMI group 25. Statistical significances for the unadjusted 
hypothesis of linearity across categories of maternal BMI were evaluated by using the Cochran-
Armitage test for trend and analysis of variance with an appropriate contrast. Adjusted hypothesis 
of linearity (orthogonal polynomial) was evaluated using analysis of covariance. Models were 
adjusted for age, BMI, smoking and LTPA as covariates. The bootstrap method was used when the 
theoretical distribution of the test statistics was unknown or in the case of violation of the 
assumptions (e.g. non-normality). The normality of variables was evaluated using the Shapiro–Wilk 




Table 1 shows maternal and neonatal characteristics according to quartiles of maternal BMI. 
Women in the highest maternal BMI quartile were older at the time of delivery, had a bigger BSA 
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and a higher parity. Gestational age, birth weight, birth length and ponderal index increased across 
the maternal BMI quartiles. 
Table 2 shows adult characteristics according to maternal BMI quartiles for men and women. Both 
among men and women, the subjects’ own BSA, adult weight, BMI and lean body mass increased 
across the maternal BMI quartiles. Women had a bigger waist circumference and a higher body fat 
percentage in the higher maternal BMI groups. 
In men, no difference was observed in FPG according to maternal BMI (results not shown). In men 
2-hour glucose concentration was 6.56 mmol/l in the highest maternal BMI group and 7.24 mmol/l 
in the lowest group (p for trend across maternal BMI quartiles <0.001, adjusted for age, BMI, 
smoking and LTPA). HOMA-IR was 2.78 in the lowest maternal BMI quartile, 2.61 in maternal 
BMI quartiles II and III and 2.66 in the highest maternal BMI quartile (p for trend 0.049 across 
maternal BMI quartiles adjusted for age, BMI, smoking and LTPA). There were no significant 
differences in women in fasting or 2-hour glucose concentrations nor in HOMA-IR according to 
maternal BMI. 
Figure 1 shows fasting and 2-hour plasma glucose concentrations according to quartiles of maternal 
BMI for men and women across adult BMI groups. In men with BMI <25.0 kg/m2, there was a 
significant decrease in 2-hour glucose concentrations across maternal BMI groups (p for trend 
=0.002 after adjustment for age, BMI, smoking and LTPA). Similar results were observed in men 
with BMI between 25.0 and 29.9 kg/m2 (adjusted p for trend=0.023). No such trend was observed 
in FPG and maternal BMI in men. There were no significant associations between maternal BMI 
and glucose concentrations in women in different adult BMI groups. 
Figure 2 shows the trend of HOMA-IR according to quartiles of maternal BMI for men and women 
across adult BMI groups. In men with BMI ≥30 kg/m2, there was a decrease in HOMA-IR across 
maternal BMI groups (p for trend =0.049, adjusted for age, BMI, smoking and LTPA). There was 
no significant difference in HOMA-IR according to maternal BMI in non-obese men nor in women. 
In men, lean body mass increased across maternal BMI (p for trend 0.043 adjusted for age, BMI, 
smoking and LTPA, results not shown). In women the corresponding p-value was 0.18 (adjusted for 
age, BMI, smoking and LTPA, results not shown). 
 
Discussion 
Within a cohort of 1,440 non-diabetic subjects from the HBCS, we investigated the impact of 
maternal adiposity on adult offspring glucose concentrations and insulin sensitivity, according to 
subjects own BMI. A high maternal BMI was related with a better glucose metabolism, especially 
in non-obese men. Furthermore, maternal BMI was linked to a better insulin sensitivity in obese 
men. In women, there was no association between maternal BMI and glucose-insulin metabolism. 
The strengths of this study include a long follow up period and reliable information about the 
mothers and the subjects at birth from hospital birth records. In this study, the subjects were 
followed up from birth until the mean age of 62 years. The subjects’ adulthood characteristic, such 
as weight and height, were reliably measured at clinical examinations. Plasma glucose and insulin 
concentrations were retrieved from a blood test taken at the clinical examination and HOMA-IR is 
considered to be an appropriate tool for measuring insulin sensitivity in epidemiological studies 26. 
We also had the possibility to adjust for variables that are often lacking in epidemiological studies, 
such as smoking status and physical activity. 
A limitation to this study is that the analyses are based on maternal BMI prior to delivery, since we 
do not have information about pre-pregnancy BMI. Neither were we able to adjust for gestational 
diabetes, since it was not diagnosed in pregnant women in Finland in 1930s and 1940s. Gestational 
diabetes has been linked to unfavorable effects on maternal and cord blood metabolomes that may 
mediate programming of obesity and cardiovascular events 27. However, maternal obesity is 
independently associated with adverse offspring neonatal outcomes also in mothers with gestational 
diabetes 28. As with most observational studies regarding developmental origins of diseases, we are 
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unable to differentiate the underlying impact of genetic, environmental and epigenetic factors or to 
confirm causality. Further, we do not have information about paternal characteristics’, since 
information about the fathers was not available from hospital records. We are thus unable to 
elucidate the influences of paternal genetic and epigenetic traits. Hypothetically, paternal weight 
could alter the results in a way that we are not able to detect due to lack of data. 
This study includes subjects who were alive and healthy enough to attend a clinical examination at 
mean age of 62 years and who did not suffer from diabetes at the time. We excluded subjects with 
diabetes, so that diabetes and diabetes medication would not interfere with the glucose and insulin 
measurements. On the other hand, the requirement of offspring survival until adult age and the 
exclusion of subjects with diabetes may cause a selection bias. 
Previous studies have shown associations between maternal adiposity and offspring obesity and 
cardiovascular risk factors in children, adolescents and young adults 11-18. However, only a few 
studies have focused on the risk of diabetes and cardiovascular disease in offspring in late 
adulthood according to maternal adiposity 19,20,23. In HBCS, we have previously shown an 
association between maternal BMI and type 2 diabetes in adult offspring, particularly in women, but 
not between maternal BMI and offspring fasting glucose concentration or HOMA-IR 20,23. The 
present study adds to previous studies by focusing solely on non-diabetic offspring and by 
simultaneously taking offspring own adult BMI into account. In addition, we included 2-hour 
glucose concentration as a main outcome. 
Differences in adult body composition might partly explain the results. Preceding studies from 
HBCS have shown that low birth weight predicted lower lean body mass in adulthood and that a 
high birth weight in combination with a high maternal BMI was associated with an adverse body 
composition in adulthood 23,29. In this study, men and women with higher maternal BMI had a 
higher lean body mass in the crude model. After adjustment for age, BMI, smoking and LTPA, 
there was a significant positive relationship between maternal BMI and lean body mass, but only in 
men. There is some evidence suggesting that a low muscle mass is a risk factor for type 2 diabetes 
and that it is also associated with poorer glucose metabolism and insulin sensitivity in subjects 
without diabetes 30,31. Skeletal muscle is a major organ of glucose uptake during postprandial 
hyperglycemia 32. In the present study, the increase in lean body mass with higher maternal BMI 
may be a protective factor for glucose intolerance. On the other hand, type 2 diabetes is also 
associated with an excessive loss of skeletal muscle mass, hence complicating the interpretation of 
the results 33.  
We observed different outcomes in men and women. There are sex differences in the development 
of type 2 diabetes and men are diagnosed with diabetes at a lower age and with a lower BMI than 
women 34. In mice, maternal high fat diet leads to higher oxidative stress in beta cells in male 
offspring, and in female offspring, estradiol seems to protect from oxidative stress 35. Additionally, 
sex differences are well reported in previous studies regarding maternal obesity and offspring later 
health 36. 
Our findings provide novel information about the long-term effects of maternal BMI on glucose 
metabolism in the offspring. Obesity in pregnant women has increased in prevalence globally, 
resulting in an urgent need to better understand the long-term consequences of maternal obesity 2. 
Further understanding of these associations may improve primary prevention of obesity in young 
women and, consequently, of cardiometabolic outcomes in the offspring. 
In conclusion, we have studied the association between maternal BMI and glucose and insulin 
metabolism in non-diabetic offspring in adult life. Our main finding is that a high maternal BMI 
was associated with better glucose tolerance in non-obese men. The results may in part be explained 
by the increase in lean body mass, which may be a protective factor for glucose intolerance. This 
study gives further insight in the complex associations between maternal adiposity and offspring 
cardiometabolic outcomes later in life. 
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Table 1. Maternal and neonatal characteristics according to quartiles of maternal body mass index 
during late pregnancy. Data are presented as mean (SD) or number (%). 
 










BMI, (kg/m2), range <24.6 24.6-26.2 26.3-28.0 >28.0  
Maternal      
   Age (years) 27.3 (5.2) 28.0 (5.4) 28.8 (5.3) 30.4 (5.5) <0.001 
   Weight (kg) 60.0 (4.6) 64.9 (4.9) 69.4 (5.2) 76.1 (6.7) <0.001 
   Length (cm) 160.5 (6.1) 159.8 (5.9) 159.8(6.0) 158.6 (5.4) <0.001 
   BSA† (m2) 1.63 (0.09) 1.70 (0.09) 1.75 0.10) 1.83 (0.10) <0.001 
   Parity 1.6 (1.0) 1.8 (1.2) 2.0 (1.3) 2.2 (1.5) <0.001 
Neonatal      
   Boys, n (%) 163 (46) 178 (49) 142 (40) 153 (42) 0.10 
   Gestational age (weeks) 39.8 (1.6) 40.0 (1.6) 40.0 (1.5) 40.2 (1.5) 0.003 
   Weight (g) 
      Boys 
















   Length (cm) 
      Boys 
















   Ponderal index (kg/m3) 
      Boys 
















†Calculated with Mosteller formula 




Table 2. Adult offspring anthropometry and clinical characteristics for men and women according 
to quartiles of maternal body mass index during late pregnancy. Data are presented as mean (SD) or 
number (%). 
 












Women, n 194 185 217 208  
   Age (years) 62 (3) 62 (3) 61 (3) 61 (3) 0.17 
   Height (cm) 163 (6) 163 (6) 164 (6) 163 (5) 0.62 
   Weight (kg) 70.0 (11.5) 72.5 (12.4) 72.8 (13.5) 75.1 (14.2) <0.001 
   BMI (kg/m2) 26.3 (4.1) 27.2 (4.4) 27.0 (4.7) 28.4 (5.4) <0.001 
   Waist (cm) 88 (10) 89 (12) 89 (13) 92 (13) <0.001 
   Current smokers, n (%) 41 (21) 38 (21) 50 (23) 46 (22) 0.68 
   Lean body mass (kg) 46.1(5.3) 47.6(5.3) 48.0(5.8) 47.9(5.2) <0.001 
   Fat % 33.0(6.5) 33.0(6.6) 32.8(7.0) 34.8(7.3) 0.016 
   BSA† 1.78(0.16) 1.81(0.16) 1.82(0.18) 1.83(0.18) <0.001 
   LTPA (met/wk) 46.5 (34.8) 48.8 (37.8) 44.9 (40.7) 46.2 (49.0) 0.73 
   Blood pressure (mmHg)      
      Systolic 144 (21) 142 (20) 142 (20) 143 (22) 0.96 
      Diastolic 88 (9) 87 (11) 87 (10) 88 (11) 0.98 
   Cholesterol (mmol/L) 6.16 (1.08) 6.18 (0.95) 6.12 (1.00) 6.09 (1.01) 0.42 
   LDL-cholesterol (mmol/L) 3.72 (0.94) 3.80 (0.82) 3.74 (0.88) 3.77 (0.89) 0.76 
   HDL-cholesterol (mmol/L) 1.79 (0.43) 1.77 (0.47) 1.77 (0.42) 1.70 (0.39) 0.041 
   Triglycerides (mmol/L) 1.47 (0.77) 1.35 (0.70) 1.34 (0.70) 1.41 (0.73) 0.43 
   hs-CRP (mg/L) 3.33 (4.99) 3.68 (5.58) 3.05 (4.14) 3.16 (5.06) 0.46 
Men, n 163 178 142 153  
   Age (years) 62 (3) 61 (3) 61 (3) 62 (3) 0.80 
   Height (cm) 176 (6) 177 (6) 177 (6) 177 (6) 0.16 
   Weight (kg) 82.3 (11.8) 84.8 (12.2) 84.6 (13.2) 85.9 (13.8) 0.021 
   BMI (kg/m 2) 26.6 (3.4) 27.0 (3.6) 26.9 (3.9) 27.4 (4.0) 0.069 
   Waist (cm) 98 (9) 99 (10) 99 (11) 101 (12) 0.11 
   Current smokers, n (%) 37 (23) 50 (28) 51 (36) 61 (40) <0.001 
   Lean body mass (kg) 62.8(7.2) 64.7(7.5) 65.1(7.9) 65.0(8.0) 0.009 
   Fat % 23.1(5.1) 23.1(5.4) 22.3(6.3) 23.7(5.6)  0.54 
   BSA† 2.00(0.16) 2.04(0.16) 2.03(0.17) 2.05(0.18) 0.021 
   LTPA (met/wk) 49.3 (40.1) 46.0 (47.4) 41.8 (34.4) 45.9 (36.4) 0.30 
   Blood pressure (mmHg)      
      Systolic 147 (18) 146 (20) 144 (20 144 (18) 0.087 
      Diastolic 90 (9) 91 (10) 90 (11) 89 (11) 0.25 
   Cholesterol (mmol/L) 5.75 (1.04) 5.84 (1.07) 5.91 (0.99) 5.81 (1.03) 0.55 
   LDL-cholesterol (mmol/L) 3.62 (0.89) 3.68 (0.88) 3.73 (0.79) 3.64 (0.84) 0.72 
   HDL-cholesterol (mmol/L) 1.45 (0.34) 1.49 (0.36) 1.51 (0.41) 1.49 (0.43) 0.32 
   Triglycerides (mmol/L) 1.55 (0.78) 1.47 (0.77) 1.48 (0.78) 1.46 (0.74) 0.35 
   hs-CRP (mg/L) 2.90 (4.43) 2.56 (3.52) 2.49 (3.25) 3.81(7.66) 0.22 
†Calculated with Mosteller formula 
BMI Body Mass Index, BSA Body Surface Area, LTPA Leisure Time Physical Activity, MET 
Metabolic Equivalent of Task, Hs-CRP High sensitive C-reactive protein   
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Figure 1. Fasting (FPG) and 2-hour plasma glucose (2hPG) according to quartiles of maternal body 
mass index during late pregnancy in men and women in different adulthood body mass index 











Figure 2. HOMA-IR according to quartiles of maternal body mass index in late pregnancy in men 
and women in different adulthood body mass index groups (values adjusted for age, BMI, smoking 
and LTPA).  
 
 
 
 
 
